FDA Grants Emergency-Use Status To Abbott’s $5 COVID-19 Rapid Antigen Test

The U.S. Food and Drug Administration has granted emergency-use authorization to Abbott Laboratories for a $5 rapid-response COVID-19 antigen test. The test results can be read directly from the testing card, a similar design to some pregnancy tests. This simple design is fast and efficient for health care provider organizations and consumers and does not need the use of an analyzer.

A health care professional swabs the individual’s nose and twirls that sample on a test card with a testing reagent added. After waiting 15 minutes, the professional reads the results directly from the testing . . .